HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victoria Naranjo Selected Research

Infections

12/2008Differential expression of the tick protective antigen subolesin in anaplasma marginale- and A. phagocytophilum-infected host cells.
12/2008Silencing expression of the defensin, varisin, in male Dermacentor variabilis by RNA interference results in reduced Anaplasma marginale infections.
2/2008Expression of perilipin in human promyelocytic cells in response to Anaplasma phagocytophilum infection results in modified lipid metabolism.
1/2008Prevalence of Coxiella burnetti infection in wild and farmed ungulates.
9/2007Sp110 transcription is induced and required by Anaplasma phagocytophilum for infection of human promyelocytic cells.
6/2007Comparative genomics and proteomics to study tissue-specific response and function in natural Mycobacterium bovis infections.
10/2006Molecular epidemiology of human and bovine anaplasmosis in southern Europe.
10/2006Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
6/2005Genetic diversity of anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development.
4/2005Gene expression profiling of human promyelocytic cells in response to infection with Anaplasma phagocytophilum.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victoria Naranjo Research Topics

Disease

11Infections
12/2008 - 01/2005
10Tick Infestations
02/2010 - 06/2005
5Anaplasmosis
07/2008 - 06/2005
1Bacterial Infections (Bacterial Infection)
01/2013
1Bovine Tuberculosis
05/2009
1Hemolysis
06/2007
1Tuberculosis (Tuberculoses)
01/2007
1Inflammation (Inflammations)
03/2006
1Persistent Infection
06/2005

Drug/Important Bio-Agent (IBA)

9VaccinesIBA
02/2010 - 06/2005
5AntigensIBA
07/2009 - 07/2006
3Arthropod ProteinsIBA
02/2010 - 06/2005
3Proteins (Proteins, Gene)FDA Link
07/2009 - 10/2006
2DNA (Deoxyribonucleic Acid)IBA
07/2008 - 03/2006
2Messenger RNA (mRNA)IBA
02/2008 - 09/2007
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2006 - 06/2005
1NF-kappa B (NF-kB)IBA
01/2013
1DefensinsIBA
12/2008
1Recombinant DNA (Recombinant DNA Research)IBA
02/2008
1Perilipin-1IBA
02/2008
1AntibodiesIBA
01/2008
1SeleniumIBA
06/2007
1Recombinant ProteinsIBA
12/2006
1Ribosomal DNA (rDNA)IBA
10/2006
1Biological ProductsIBA
10/2006
1RNA (Ribonucleic Acid)IBA
03/2006
1Carrier Proteins (Binding Protein)IBA
03/2006
1PolynucleotidesIBA
04/2005
116S Ribosomal RNAIBA
01/2005